Goldman Sachs lowered the firm’s price target on Visteon to $161 from $176 and keeps a Buy rating on the shares. The analyst cites the company having updated its 2026 sales outlook to $5.0B, down from $5.5B, though the management maintained its low double digit growth over market expectation. Goldman Sachs adds however that Visteon remains well positioned for growth, as evidenced by another year of strong bookings and resilient margins.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
See today’s best-performing stocks on TipRanks >>
Read More on VC:
- Visteon Reveals Financial Health and Leadership Updates
- Visteon Announces 2023 Financial Results and 2024 Outlook
- Visteon to Announce Fourth Quarter and Full-Year 2023 Results on Feb. 20
- Visteon price target lowered to $148 from $160 at JPMorgan
- Visteon price target lowered to $140 from $158 at Barclays
